What is the current annual revenue of IQV?

As of today, IQV annual revenue is $16.30B

What is 1-year change in IQV annual revenue?

IQV annual revenue is up +5.84% year-over-year

What is 3-year change in IQV annual revenue?

IQV annual revenue is up +13.07% over the past 3 years

How far is IQV annual revenue from its all-time high?

IQV annual revenue is currently at its all-time high

How does IQV annual revenue rank versus sector peers?

IQV annual revenue is higher than 96.56% of companies in Healthcare sector

How does the analyst estimate for IQV annual revenue compare to its current value?

Analysts estimate IQV annual revenue at $17.41B, +6.81% higher than the current value

When is IQV next annual earnings release?

As of today, the next annual earnings release for IQV has not been scheduled

What is the current quarterly revenue of IQV?

As of today, IQV quarterly revenue is $4.37B

What is IQV quarterly revenue most recent change?

IQV quarterly revenue was up +5.07% on June 30, 2026

What is 1-year change in IQV quarterly revenue?

IQV quarterly revenue is up +8.84% year-over-year

How far is IQV quarterly revenue from its all-time high?

IQV quarterly revenue is currently at its all-time high

How does IQV quarterly revenue rank versus sector peers?

IQV quarterly revenue is higher than 96.34% of companies in Healthcare sector

How does the analyst estimate for IQV quarterly revenue compare to its current value?

Analysts estimate IQV quarterly revenue at $4.36B, -0.17% lower than the current value

When is IQV next earnings release?

The next earnings release for IQV is on November 3, 2026

What is the current TTM revenue of IQV?

As of today, IQV TTM revenue is $16.99B

What is IQV TTM revenue most recent change?

IQV TTM revenue was up +2.13% on June 30, 2026

What is 1-year change in IQV TTM revenue?

IQV TTM revenue is up +8.22% year-over-year

How far is IQV TTM revenue from its all-time high?

IQV TTM revenue is currently at its all-time high

How does IQV TTM revenue rank versus sector peers?

IQV TTM revenue is higher than 96.34% of companies in Healthcare sector

How does the analyst estimate for IQV TTM revenue compare to its current value?

Analysts estimate IQV TTM revenue at $17.25B, +1.55% higher than the current value

When is IQV next earnings release?

The next earnings release for IQV is on November 3, 2026

IQV Revenue History & Chart Since 2010

Annual Revenue

$16.30B$899.00M+5.84%

December 31, 2025

Summary

Current Value: As of today, IQV annual revenue is $16.30B, up +5.84% on December 31, 2025
Historical Performance: IQV annual revenue is up +13.07% over the past 3 years, up +43.55% over the past 5 years
All-Time High Comparison: IQV annual revenue is currently at its all-time high
3-Year Low Comparison: IQV annual revenue is +13.07% above its 3-year low of $14.42B reached on an earlier date
Sector Comparison: IQV annual revenue is higher than 96.56% of companies in Healthcare sector
Analyst Estimate: Analysts estimate IQV annual revenue at $17.41B, +6.81% higher than the current value
Upcoming Earnings: As of today, the next annual earnings release for IQV has not been scheduled

Revenue Chart

Performance

IQV Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual Revenue	Dec 31, 25	$16.30B	+5.8%	+13.1%	+43.5%	+315.5%
Quarterly Revenue	Jun 30, 26	$4.37B	+8.8%	+17.5%	+27.2%	+431.3%
TTM Revenue	Jun 30, 26	$16.99B	+8.2%	+15.9%	+31.5%	+959.5%
Price	Aug 13, 26	$241.52	+27.0%	+9.9%	-2.7%	–
Annual EPS	Dec 31, 25	$7.84	+4.7%	+36.9%	+447.9%	+529.2%
PE Ratio	Aug 13, 26	29.96	+8.7%	-20.7%	-62.4%	–
Annual Gross Profit	Dec 31, 25	$4.29B	+0.6%	+9.7%	+66.7%	+283.0%
Annual Net Income	Dec 31, 25	$1.36B	-0.9%	+24.8%	+341.9%	+723.6%
Annual EBITDA	Dec 31, 25	$3.43B	+1.4%	+15.6%	+65.8%	+579.4%
	Dec 31, 25	$2.29B	+0.8%	+24.5%	+192.5%	+443.5%

Revenue Highs

IQV Annual Revenue Highs Comparison
Period	High	Date	Current
3Y	$16.30B	Dec 31, 25	at high
5Y	$16.30B	Dec 31, 25	at high
All	$16.30B	Dec 31, 25	at high

Revenue Lows

IQV Annual Revenue Lows Comparison
Period	Low	Date	Current
3Y	$14.42B	N/A	+13.1%
5Y	$11.36B	N/A	+43.5%
All	$3.92B	Dec 31, 10	+315.5%

Revenue Estimates

IQV Revenue Estimates reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2024	$15.38B	$15.41B	+0.17%
2025	$16.18B	$16.30B	+0.74%
2026	$17.41B	N/A	+6.81%
2027	$18.47B	N/A	+13.28%

🔒 Log In To Unlock Full Data

Revenue History

Year	Value	Change
2025	$16.30B	+5.8%
2024	$15.41B	+3.0%
2023	$14.96B	+3.8%
2022	$14.42B	+3.9%
2021	$13.88B	+22.2%
2020	$11.36B	+2.4%
2019	$11.09B	+6.5%
2018	$10.41B	+7.3%

Year	Value	Change
2017	$9.71B	+40.8%
2016	$6.90B	+20.1%
2015	$5.74B	+5.3%
2014	$5.46B	+7.0%
2013	$5.10B	+4.8%
2012	$4.87B	+12.4%
2011	$4.33B	+10.3%
2010	$3.92B	-

FAQ

What is the current annual revenue of IQV?: As of today, IQV annual revenue is $16.30B
What is 1-year change in IQV annual revenue?: IQV annual revenue is up +5.84% year-over-year
What is 3-year change in IQV annual revenue?: IQV annual revenue is up +13.07% over the past 3 years
How far is IQV annual revenue from its all-time high?: IQV annual revenue is currently at its all-time high
How does IQV annual revenue rank versus sector peers?: IQV annual revenue is higher than 96.56% of companies in Healthcare sector
How does the analyst estimate for IQV annual revenue compare to its current value?: Analysts estimate IQV annual revenue at $17.41B, +6.81% higher than the current value
When is IQV next annual earnings release?: As of today, the next annual earnings release for IQV has not been scheduled

Quarterly Revenue

$4.37B$211.00M+5.07%

June 30, 2026

Summary

Current Value: As of today, IQV quarterly revenue is $4.37B, up +5.07% on June 30, 2026
Historical Performance: IQV quarterly revenue is up +8.84% year-over-year, up +17.47% over the past 3 years
All-Time High Comparison: IQV quarterly revenue is currently at its all-time high
3-Year Low Comparison: IQV quarterly revenue is +17.47% above its 3-year low of $3.72B reached on an earlier date
Sector Comparison: IQV quarterly revenue is higher than 96.34% of companies in Healthcare sector
Analyst Estimate: Analysts estimate IQV quarterly revenue at $4.36B, -0.17% lower than the current value
Upcoming Earnings: The next earnings release for IQV is on November 3, 2026

Performance

IQV Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Revenue	Jun 30, 26	$4.37B	+5.1%	+8.8%	+17.5%	+27.2%
Annual Revenue	Dec 31, 25	$16.30B	–	+5.8%	+13.1%	+43.5%
TTM Revenue	Jun 30, 26	$16.99B	+2.1%	+8.2%	+15.9%	+31.5%
Price	Aug 13, 26	$241.52	+40.1%	+27.0%	+9.9%	-2.7%
Quarterly EPS	Jun 30, 26	$1.53	-5.2%	-0.4%	-3.8%	+70.4%
PE Ratio	Aug 13, 26	29.96	+40.2%	+8.7%	-20.7%	-62.4%
Quarterly Gross Profit	Jun 30, 26	$1.14B	+6.3%	+9.4%	+12.3%	+48.4%
Quarterly Net Income	Jun 30, 26	$258.00M	-6.2%	-3.0%	-13.1%	+47.4%
	Jun 30, 26	$569.00M	-0.7%	+6.2%	+6.2%	+97.6%
Quarterly EBITDA	Jun 30, 26	$863.00M	+0.2%	+6.3%	+8.6%	+36.8%

Quarterly Revenue Highs

IQV Quarterly Revenue Highs Comparison
Period	High	Date	Current
1Y	$4.37B	Jun 30, 26	at high
3Y	$4.37B	Jun 30, 26	at high
5Y	$4.37B	Jun 30, 26	at high
All	$4.37B	Jun 30, 26	at high

Quarterly Revenue Lows

IQV Quarterly Revenue Lows Comparison
Period	Low	Date	Current
1Y	$4.02B	N/A	+8.8%
3Y	$3.72B	N/A	+17.5%
5Y	$3.39B	Sep 30, 21	+28.9%
All	$780.90M	Mar 1, 11	+459.6%

Quarterly Revenue Estimates

IQV Quarterly Revenue Estimates reported versus estimate values
Month	Estimate	Reported	Surprise / Exp.
Mar 2026	$4.10B	$4.16B	+1.44%
Jun 2026	$4.30B	$4.37B	+1.58%
Sep 2026	$4.36B	N/A	-0.17%
Dec 2026	$4.54B	N/A	+3.78%

🔒 Log In To Unlock Full Data

Quarterly Revenue History

Month	Value	Change
Jun 2026	$4.37B	+5.1%
Mar 2026	$4.16B	-4.6%
Dec 2025	$4.36B	+6.3%
Sep 2025	$4.10B	+2.1%
Jun 2025	$4.02B	+4.8%
Mar 2025	$3.83B	-3.2%
Dec 2024	$3.96B	+1.7%
Sep 2024	$3.89B	+2.1%
Jun 2024	$3.81B	+2.0%
Mar 2024	$3.74B	-3.3%
Dec 2023	$3.87B	+3.4%
Sep 2023	$3.74B	+0.6%
Jun 2023	$3.72B	+2.3%
Mar 2023	$3.64B	-3.0%
Dec 2022	$3.75B	+5.4%
Sep 2022	$3.55B	+0.1%
Jun 2022	$3.55B	-0.5%
Mar 2022	$3.57B	-1.8%
Dec 2021	$3.64B	+7.3%
Sep 2021	$3.39B	-1.3%
Jun 2021	$3.44B	+0.9%
Mar 2021	$3.41B	+3.6%
Dec 2020	$3.29B	+17.8%
Sep 2020	$2.79B	+10.5%
Jun 2020	$2.52B	-8.4%
Mar 2020	$2.76B	-4.9%
Dec 2019	$2.90B	+4.5%
Sep 2019	$2.77B	+1.1%
Jun 2019	$2.74B	+2.0%
Mar 2019	$2.69B	-0.2%
Dec 2018	$2.69B	+3.7%

Month	Value	Change
Sep 2018	$2.60B	+1.1%
Jun 2018	$2.57B	+0.2%
Mar 2018	$2.56B	+1.3%
Dec 2017	$2.53B	+2.5%
Sep 2017	$2.47B	+4.5%
Jun 2017	$2.36B	-0.3%
Mar 2017	$2.37B	-0.2%
Dec 2016	$2.37B	+57.7%
Sep 2016	$1.50B	-3.4%
Jun 2016	$1.56B	+4.2%
Mar 2016	$1.49B	-1.9%
Dec 2015	$1.52B	+6.8%
Sep 2015	$1.43B	-1.4%
Jun 2015	$1.45B	+7.1%
Mar 2015	$1.35B	-4.4%
Dec 2014	$1.41B	+0.9%
Sep 2014	$1.40B	+4.5%
Jun 2014	$1.34B	+2.5%
Mar 2014	$1.31B	-5.2%
Dec 2013	$1.38B	+15.2%
Sep 2013	$1.20B	-7.7%
Jun 2013	$1.30B	+5.4%
Mar 2013	$1.23B	+29.9%
Dec 2012	$945.76M	+3.5%
Sep 2012	$913.59M	-3.3%
Jun 2012	$944.91M	+6.4%
Mar 2012	$888.04M	+1.8%
Dec 2011	$872.14M	+6.4%
Sep 2011	$819.45M	-0.4%
Jun 2011	$822.48M	+5.3%
Mar 2011	$780.90M	-

FAQ

What is the current quarterly revenue of IQV?: As of today, IQV quarterly revenue is $4.37B
What is IQV quarterly revenue most recent change?: IQV quarterly revenue was up +5.07% on June 30, 2026
What is 1-year change in IQV quarterly revenue?: IQV quarterly revenue is up +8.84% year-over-year
How far is IQV quarterly revenue from its all-time high?: IQV quarterly revenue is currently at its all-time high
How does IQV quarterly revenue rank versus sector peers?: IQV quarterly revenue is higher than 96.34% of companies in Healthcare sector
How does the analyst estimate for IQV quarterly revenue compare to its current value?: Analysts estimate IQV quarterly revenue at $4.36B, -0.17% lower than the current value
When is IQV next earnings release?: The next earnings release for IQV is on November 3, 2026

TTM Revenue

$16.99B$355.00M+2.13%

June 30, 2026

Summary

Current Value: As of today, IQV TTM revenue is $16.99B, up +2.13% on June 30, 2026
Historical Performance: IQV TTM revenue is up +8.22% year-over-year, up +15.90% over the past 3 years
All-Time High Comparison: IQV TTM revenue is currently at its all-time high
3-Year Low Comparison: IQV TTM revenue is +15.90% above its 3-year low of $14.66B reached on an earlier date
Sector Comparison: IQV TTM revenue is higher than 96.34% of companies in Healthcare sector
Analyst Estimate: Analysts estimate IQV TTM revenue at $17.25B, +1.55% higher than the current value
Upcoming Earnings: The next earnings release for IQV is on November 3, 2026

Performance

IQV Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM Revenue	Jun 30, 26	$16.99B	+2.1%	+8.2%	+15.9%	+31.5%
Annual Revenue	Dec 31, 25	$16.30B	–	+5.8%	+13.1%	+43.5%
Quarterly Revenue	Jun 30, 26	$4.37B	+5.1%	+8.8%	+17.5%	+27.2%
Price	Aug 13, 26	$241.52	+40.1%	+27.0%	+9.9%	-2.7%
TTM EPS	Jun 30, 26	$8.06	-0.1%	+16.8%	+38.5%	+158.9%
PE Ratio	Aug 13, 26	29.96	+40.2%	+8.7%	-20.7%	-62.4%
TTM Gross Profit	Jun 30, 26	$4.42B	+2.3%	+3.9%	+11.3%	+47.1%
TTM Net Income	Jun 30, 26	$1.38B	-0.6%	+11.5%	+25.8%	+118.9%
TTM EBITDA	Jun 30, 26	$3.55B	+1.5%	+4.8%	+18.5%	+44.2%
	Jun 30, 26	$2.36B	+1.4%	+4.4%	+25.9%	+109.0%

TTM Revenue Highs

IQV TTM Revenue Highs Comparison
Period	High	Date	Current
1Y	$16.99B	Jun 30, 26	at high
3Y	$16.99B	Jun 30, 26	at high
5Y	$16.99B	Jun 30, 26	at high
All	$16.99B	Jun 30, 26	at high

TTM Revenue Lows

IQV TTM Revenue Lows Comparison
Period	Low	Date	Current
1Y	$15.70B	N/A	+8.2%
3Y	$14.66B	N/A	+15.9%
5Y	$12.92B	N/A	+31.5%
All	$780.90M	Mar 1, 11	+2075.3%

TTM Revenue History

Month	Value	Change
Jun 2026	$16.99B	+2.1%
Mar 2026	$16.63B	+2.0%
Dec 2025	$16.30B	+2.5%
Sep 2025	$15.90B	+1.3%
Jun 2025	$15.70B	+1.3%
Mar 2025	$15.50B	+0.6%
Dec 2024	$15.41B	+0.6%
Sep 2024	$15.31B	+1.0%
Jun 2024	$15.16B	+0.6%
Mar 2024	$15.07B	+0.7%
Dec 2023	$14.96B	+0.8%
Sep 2023	$14.84B	+1.3%
Jun 2023	$14.66B	+1.2%
Mar 2023	$14.49B	+0.5%
Dec 2022	$14.42B	+0.8%
Sep 2022	$14.31B	+1.2%
Jun 2022	$14.15B	+0.8%
Mar 2022	$14.03B	+1.2%
Dec 2021	$13.87B	+2.6%
Sep 2021	$13.52B	+4.6%
Jun 2021	$12.92B	+7.6%
Mar 2021	$12.01B	+5.7%
Dec 2020	$11.36B	+3.6%
Sep 2020	$10.97B	+0.2%
Jun 2020	$10.95B	-1.9%
Mar 2020	$11.16B	+0.6%
Dec 2019	$11.09B	+1.9%
Sep 2019	$10.89B	+1.6%
Jun 2019	$10.71B	+1.7%
Mar 2019	$10.54B	+1.2%
Dec 2018	$10.41B	+1.6%

Month	Value	Change
Sep 2018	$10.25B	+1.3%
Jun 2018	$10.12B	+2.1%
Mar 2018	$9.91B	+2.0%
Dec 2017	$9.72B	+1.6%
Sep 2017	$9.56B	+11.2%
Jun 2017	$8.60B	+10.3%
Mar 2017	$7.79B	+12.6%
Dec 2016	$6.92B	+14.0%
Sep 2016	$6.08B	+1.3%
Jun 2016	$6.00B	+1.9%
Mar 2016	$5.89B	+2.5%
Dec 2015	$5.74B	+2.0%
Sep 2015	$5.63B	+0.5%
Jun 2015	$5.61B	+1.9%
Mar 2015	$5.50B	+0.8%
Dec 2014	$5.46B	+0.6%
Sep 2014	$5.42B	+3.9%
Jun 2014	$5.22B	+0.8%
Mar 2014	$5.18B	+1.5%
Dec 2013	$5.10B	+9.3%
Sep 2013	$4.67B	+6.4%
Jun 2013	$4.38B	+8.7%
Mar 2013	$4.03B	+9.2%
Dec 2012	$3.69B	+2.0%
Sep 2012	$3.62B	+2.7%
Jun 2012	$3.52B	+3.6%
Mar 2012	$3.40B	+3.3%
Dec 2011	$3.29B	+36.0%
Sep 2011	$2.42B	+51.1%
Jun 2011	$1.60B	+105.3%
Mar 2011	$780.90M	-

FAQ

What is the current TTM revenue of IQV?: As of today, IQV TTM revenue is $16.99B
What is IQV TTM revenue most recent change?: IQV TTM revenue was up +2.13% on June 30, 2026
What is 1-year change in IQV TTM revenue?: IQV TTM revenue is up +8.22% year-over-year
How far is IQV TTM revenue from its all-time high?: IQV TTM revenue is currently at its all-time high
How does IQV TTM revenue rank versus sector peers?: IQV TTM revenue is higher than 96.34% of companies in Healthcare sector
How does the analyst estimate for IQV TTM revenue compare to its current value?: Analysts estimate IQV TTM revenue at $17.25B, +1.55% higher than the current value
When is IQV next earnings release?: The next earnings release for IQV is on November 3, 2026

Data Sources & References

IQV Official Website www.iqvia.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1478242/000119312525312900/0001193125-25-312900-index.htm
IQV Profile on Yahoo Finance finance.yahoo.com/quote/IQV
IQV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/iqv